Budesonide

Back to search

Molecule Structure

Scientific Name

Budesonide

Description of the Drug

Budesonide is a corticosteroid used to treat Crohn’s disease, asthma, COPD, hay fever and allergies, and ulcerative colitis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01222

Brand Name(s)

Aircort, Budeflam aquanase, Budelin novolizer, Budenofalk, Budesonide, Cortiment, Duoresp spiromax, Entocort, Entocort cr, Entocort ec, Ortikos, Preferid, Pulmaxan, Pulmicort, Pulmicort flexhaler, Pulmicort l.s., Pulmicort respules, Rhinocort, Rhinocort allergy, Rhinocort aqua, Rhinocort aqua 64, Symbicort, Uceris

Company Owner(s)

Apotex Inc Richmond Hill, Salix Pharmaceuticals Inc, Impax Laboratories Inc, Alvogen Inc, Sciecure Pharma Inc, Padagis Us Llc, Sun Pharma Global Fze, Barr Laboratories Inc Sub Teva Pharmaceuticals Usa, Sun Pharmaceutical Industries Ltd, Zydus Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Glucocorticoid receptor SINGLE PROTEIN AGONIST CHEMBL2034

Unichem Links

SureChEMBL SCHEMBL4096
Human Metabolome Database HMDB0015353
DrugBank DB01222
PubChem: Thomson Pharma 14929955 14807548
PubChem 5281004
LINCS LSM-1472
Nikkaji J11.656D
BindingDB 50354850
EPA CompTox Dashboard DTXSID8020202
DrugCentral 419
Brenda 52466
ChemicalBook CB0313122
Guide to Pharmacology 7434
rxnorm ENTOCORT BUDESONIDE ORTIKOS RHINOCORT SYMBICORT UCERIS PULMICORT
PubChem: Drugs of the Future 12013315
ChEBI 3207
NIH Clinical Collection SAM002699898